National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special Exposure Cohort, 9536-9537 [07-947]

Download as PDF 9536 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices pwalker on PROD1PC71 with NOTICES The agenda will focus on the oversight of genetic testing, including the role of the private sector in assuring the quality and validity of genetic tests; the impact of gene patents and licensing practices on patient access to genetic technologies, including a progress report on the Committee’s study; and the status of Federal genetic information nondiscrimination legislation. The Committee will be briefed on the Secretary’s Personalized Health Care Initiative and the work of the American Health Information Community, particularly its Personalized Health Care Working Group. The Committee’s report on the Policy Issues Associated with Undertaking a New Large U.S. Population Cohort Project on Genes, Environment and Disease will be released at the meeting. There also will be updates on the Committee’s draft report on pharmacogenomics and several Federal initiatives and activities. Time will be provided each day for public comments. The Committee would welcome hearing from anyone wishing to provide public comment on any issue related to genetics, health and society. Individuals who would like to provide public comment should notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 301–496– 9838 or e-mail at sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting, who is in need of special assistance, such as sign language interpretation or other reasonable accommodations, is also asked to contact the Executive Secretary. Under authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established SACGHS to serve as a public forum for deliberations on the broad range of human health and societal issues raised by the development and use of genetic and genomic technologies and, as warranted, to provide advice on these issues. The draft meeting agenda and other information about SACGHS, including information about access to the Web cast, will be available at the following Web site: https:// www4.od.nih.gov/oba/sacghs.htm. Dated: February 22, 2007. Anna Snouffer, Acting Director, NIH Office of Federal Advisory Committee Policy. [FR Doc. 07–973 Filed 3–1–07; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 18:44 Mar 01, 2007 Jkt 211001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at General Atomics in La Jolla, California, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On February 16, 2007, the Secretary of HHS designated the following class of employees as an addition to the SEC: Atomic Weapons Employer (AWE) employees who were monitored or should have been monitored for exposure to ionizing radiation while working at the General Atomics facility in La Jolla, California at the following locations: Science Laboratories A, B, and C (Building 2); Experimental Building (Building 9); Maintenance (Building 10); Service Building (Building 11); Buildings 21 and 22; Hot Cell Facility (Building 23); Waste Yard (Buildings 25 and 26); Experimental Area (Buildings 27 and 27–1); LINAC Complex (Building 30); HTGR–TCF (Building 31); Fusion Building (Building 33); Fusion Doublet III (Building 34); SV–A (Building 37); SV–B (Building 39); and SV–D (no building number) for a number of work days aggregating at least 250 work days from January 1, 1960, through December 31, 1969, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation will become effective on March 18, 2007, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513– 533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Dated: February 23, 2007. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 07–948 Filed 3–1–07; 8:45 am] BILLING CODE 4160–17–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice. SUMMARY: The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Monsanto Chemical Company in Dayton, Ohio, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On February 16, 2007, the Secretary of HHS designated the following class of employees as an addition to the SEC: Atomic Weapons Employer (AWE) employees who were monitored or should have been monitored for exposure to ionizing radiation while working at Monsanto Chemical Company Units I, III, or IV in Dayton, Ohio, for a number of work days aggregating at least 250 work days during the period from January 1, 1943, through December 31, 1949, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation will become effective on March 18, 2007, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513– 533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. E:\FR\FM\02MRN1.SGM 02MRN1 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices Dated: February 23, 2007. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 07–947 Filed 3–1–07; 8:45 am] BILLING CODE 4160–17–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention pwalker on PROD1PC71 with NOTICES National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting Name: ICD–9–CM Coordination and Maintenance (C&M) Committee meeting. Time and Date: 9 a.m.–5 p.m., March 22– 23, 2007. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland. Status: Open to the public. Purpose: The C&M meeting is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth-Revision, Clinical Modification. Matters to be Discussed: Tentative agenda items include: Migraines and other headache syndromes Transplant complications Hormone therapy for breast cancer Penicillin resistant infections Central line infections Fetal medicine Plateau iris syndrome and pingueculitis Secondary diabetes mellitus Erythema multiforme Malignant pleural effusion Autoimmune hepatitis Addenda (diagnosis) Intraoperative electron radiation therapy Intraoperative neurophysiologic monitoring Thoracoscopic procedures Procedures on vena cava STARR procedure for males Oversewing of the atrial appendage Transjugular biopsy of liver Total disc replacement Recalled devices Motion preserving technologies Addenda (procedures) ICD–10 procedure coding system (PCS update) Contact Person for Additional Information: Amy Blum, Medical Systems Specialist, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, email alb8@cdc.gov, telephone 301–458–4106 (diagnosis), Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Blvd., Baltimore, Maryland 21244, e-mail marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). Notice: Because of increased security requirements, CMS has instituted stringent procedures for entrance into the building by non-government employees. Persons without VerDate Aug<31>2005 18:44 Mar 01, 2007 Jkt 211001 a government I.D. will need to show an official form of picture I.D., (such as a drivers license), and sign-in at the security desk upon entering the building. Those who wish to attend a specific ICD– 9–CM C&M meeting in the CMS auditorium must submit their name and organization for addition to the meeting visitor list. Those wishing to attend the March 22–23, 2007 meeting must submit their name and organization by March 14, 2007 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Those who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Register to attend the meeting online at: https://www.cms.hhs.gov/apps/events/. Notice: This is a public meeting. However, because of fire code requirements, should the number of attendants meet the capacity of the room, the meeting will be closed. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 26, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–3660 Filed 3–1–07; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10098 and CMS– 10114] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the Agency’s function; (2) the accuracy of the estimated AGENCY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 9537 burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: 1–800– MEDICARE Beneficiary Satisfaction Survey; Use: The Centers for Medicare & Medicaid Services will use the survey information for performance evaluation of the contractor. The information gathered will also be used to validate the quality of service delivered, and or direct the contractor to performance improvement; Form Number: CMS– 10098 (OMB#: 0938–0919); Frequency: Reporting—Weekly, Monthly and Yearly; Affected Public: Individuals or households; Number of Respondents: 18,000; Total Annual Responses: 18,000; Total Annual Hours: 2,250. 2. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: National Provider Identifier (NPI) Application and Update Form and Supporting Regulations in 45 CFR 142.408, 45 CFR 162.406, 45 CFR 162.408; Use: The National Provider Identifier (NPI) Application and Update Form is used by health care providers to apply for NPIs and furnish updates to the information they supplied on their initial applications. The form is also used to deactivate their NPIs if necessary. The NPI Application/Update form has been revised to further assist in uniquely identifying health care providers and provide additional guidance on how to accurately complete the form. The form captures additional data elements that will assist with unique identification. It also includes more detailed instructions. Form Number: CMS–10114 (OMB#: 0938– 0931); Frequency: Reporting—On occasion, one-time; Affected Public: Business or other for-profit, Not-forprofit institutions, and Federal government; Number of Respondents: 325,608; Total Annual Responses: 325,608; Total Annual Hours: 108,560. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS Web Site address at https://www.cms.hhs.gov/ PaperworkReductionActof1995, or Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the E:\FR\FM\02MRN1.SGM 02MRN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 72, Number 41 (Friday, March 2, 2007)]
[Notices]
[Pages 9536-9537]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-947]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; 
Designation of a Class of Employees for Addition to the Special 
Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) gives notice 
of a decision to designate a class of employees at the Monsanto 
Chemical Company in Dayton, Ohio, as an addition to the Special 
Exposure Cohort (SEC) under the Energy Employees Occupational Illness 
Compensation Program Act of 2000. On February 16, 2007, the Secretary 
of HHS designated the following class of employees as an addition to 
the SEC:

Atomic Weapons Employer (AWE) employees who were monitored or should 
have been monitored for exposure to ionizing radiation while working 
at Monsanto Chemical Company Units I, III, or IV in Dayton, Ohio, 
for a number of work days aggregating at least 250 work days during 
the period from January 1, 1943, through December 31, 1949, or in 
combination with work days within the parameters established for one 
or more other classes of employees in the Special Exposure Cohort.

    This designation will become effective on March 18, 2007, unless 
Congress provides otherwise prior to the effective date. After this 
effective date, HHS will publish a notice in the Federal Register 
reporting the addition of this class to the SEC or the result of any 
provision by Congress regarding the decision by HHS to add the class to 
the SEC.

FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also be submitted by e-mail to OCAS@CDC.GOV.


[[Page 9537]]


    Dated: February 23, 2007.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 07-947 Filed 3-1-07; 8:45 am]
BILLING CODE 4160-17-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.